Junshi Biosciences Reveals Reorganization Stakeholders

Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877) has released an update.

Shanghai Junshi Biosciences has provided additional details regarding the stakeholders involved in its Reorganization Framework Agreement, including ownership percentages of Med-Fine Venture Fund I, L.P., Changzhou Jifeng, and Wuhan Jifeng. The company has clarified the ownership structure of these entities, revealing significant stakes held by individual investors and other companies. This supplemental announcement follows a previous disclosure on August 30, 2024, and is intended to inform shareholders and potential investors.

For further insights into HK:1877 stock, check out TipRanks’ Stock Analysis page.